These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 15485498

  • 1. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
    Garcia AS, Barrera G, Burke TF, Ma S, Hensler JG, Morilak DA.
    J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
    [Abstract] [Full Text] [Related]

  • 2. Blockade of autoreceptor-mediated inhibition of norepinephrine release by atipamezole is maintained after chronic reuptake inhibition.
    Lapiz MD, Zhao Z, Bondi CO, O'Donnell JM, Morilak DA.
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):827-33. PubMed ID: 17697440
    [Abstract] [Full Text] [Related]

  • 3. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine.
    Bondi CO, Barrera G, Lapiz MD, Bedard T, Mahan A, Morilak DA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):482-95. PubMed ID: 17188790
    [Abstract] [Full Text] [Related]

  • 4. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
    Gobert A, Billiras R, Cistarelli L, Millan MJ.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):141-52. PubMed ID: 15589344
    [Abstract] [Full Text] [Related]

  • 5. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.
    Reynolds JL, Ignatowski TA, Sud R, Spengler RN.
    Neuroscience; 2005 Dec 30; 133(2):519-31. PubMed ID: 15878644
    [Abstract] [Full Text] [Related]

  • 6. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P, Flore G, Pira L, Longu G, Gessa GL.
    Eur J Pharmacol; 2004 Mar 08; 487(1-3):105-11. PubMed ID: 15033381
    [Abstract] [Full Text] [Related]

  • 7. Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test.
    Lapiz MD, Bondi CO, Morilak DA.
    Neuropsychopharmacology; 2007 May 08; 32(5):1000-10. PubMed ID: 17077810
    [Abstract] [Full Text] [Related]

  • 8. Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study.
    Mateo Y, Fernández-Pastor B, Meana JJ.
    Br J Pharmacol; 2001 Aug 08; 133(8):1362-70. PubMed ID: 11498523
    [Abstract] [Full Text] [Related]

  • 9. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade.
    Valentini V, Cacciapaglia F, Frau R, Di Chiara G.
    J Neurochem; 2006 Jul 08; 98(1):113-21. PubMed ID: 16805801
    [Abstract] [Full Text] [Related]

  • 10. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
    Lacroix D, Blier P, Curet O, de Montigny C.
    J Pharmacol Exp Ther; 1991 Jun 08; 257(3):1081-90. PubMed ID: 1646320
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P, Flore G, Pira L, Diana M, Gessa GL.
    Psychopharmacology (Berl); 2002 Mar 08; 160(2):220-4. PubMed ID: 11875641
    [Abstract] [Full Text] [Related]

  • 13. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.
    Invernizzi RW, Parini S, Sacchetti G, Fracasso C, Caccia S, Annoni K, Samanin R.
    Br J Pharmacol; 2001 Jan 08; 132(1):183-8. PubMed ID: 11156576
    [Abstract] [Full Text] [Related]

  • 14. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.
    Bongiovanni R, Newbould E, Jaskiw GE.
    Brain Res; 2008 Jan 23; 1190():39-48. PubMed ID: 18082673
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Paradoxical action of desipramine on the modulatory effect of bradykinin on noradrenaline release in a model of metabolic anoxia in rat isolated atria.
    Foucart S, Grondin L, Couture R, Nadeau R.
    Can J Physiol Pharmacol; 1997 Jun 23; 75(6):646-51. PubMed ID: 9276143
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies.
    Invernizzi RW, Garattini S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug 23; 28(5):819-27. PubMed ID: 15363606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.